Deepak Verma, Shruti Kapoor, Sarita Kumari, Disha Sharma, Jay Singh, Mercilena Benjamin, Sameer Bakhshi, Rachna Seth, Baibaswata Nayak, Atul Sharma, Raja Pramanik, Jayanth Kumar Palanichamy, Sridhar Sivasubbu, Vinod Scaria, Mohit Arora, Rajive Kumar, Anita Chopra
T-acute lymphoblastic leukemia (T-ALL) is a heterogeneous malignancy characterized by the abnormal proliferation of immature T-cell precursors. Despite advances in immunophenotypic classification, understanding the molecular landscape and its impact on patient prognosis remains challenging. In this study, we conducted comprehensive RNA sequencing in a cohort of 35 patients with T-ALL to unravel the intricate transcriptomic profile. Subsequently, we validated the prognostic relevance of 23 targets, encompassing (i) protein-coding genes- BAALC , HHEX , MEF2C , FAT1 , LYL1 , LMO2 , LYN , and TAL1 ; (ii) epigenetic modifiers- DOT1L , EP300 , EML4 , RAG1 , EZH2 , and KDM6A ; and (iii) long noncoding RNAs (lncRNAs)- XIST , PCAT18 , PCAT14 , LINC00202 , LINC00461 , LINC00648 , ST20 , MEF2C-AS1 , and MALAT1 in an independent cohort of 99 patients with T-ALL...
February 2024: PNAS Nexus